These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18306710)

  • 1. [Using of aphobazol in the treatment of adaptation disorder in the contract service men, dismissed from the armed forces].
    Litvintsev SV; Davydov AT; Uspenskiĭ IuP; Zagrebel'nyĭ IA; Balukova EV
    Voen Med Zh; 2007 Nov; 328(11):28-9. PubMed ID: 18306710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of the selective anxiolytic agent afobazol].
    Neznamov GG; Siuniakov SA; Chumakov DV; Bochkarev VK; Seredenin SB
    Eksp Klin Farmakol; 2001; 64(2):15-9. PubMed ID: 11548440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anxiolytic afobazole action self-evaluated by patients with anxiety-asthenic disorders].
    Reutova MA; Siuniakov SA; Siuniakov TS; Neznamov GG
    Eksp Klin Farmakol; 2010 Sep; 73(9):6-12. PubMed ID: 21086645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aphobazol--new selective anxyolytic drug].
    Neznamov GG; Siuniakov SA; Chumakov DV; Mametova LE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(4):35-40. PubMed ID: 15875941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of combined application of ursosan and anxiolytic 2-mercaptobenzimidazole in early stage of cholelithiasis].
    Vakhrushev IaM; Khokhlacheva NA
    Eksp Klin Gastroenterol; 2010; (4):105-8. PubMed ID: 20623958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of afobazole on brain-ischemia-induced anxiety in rats].
    Seredenin SB; Akopian VP; Balasanian MG; Topchian AV
    Eksp Klin Farmakol; 2006; 69(2):3-5. PubMed ID: 16845930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the continuous use of trioxazine.
    Haits G
    Ther Hung; 1976; 24(4):145-7. PubMed ID: 13509
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy of aphobazole in the treatment of anxiety disorders in patients with chronic cerebro-vascular insufficiency].
    Sholomov II; Lutoshkina EB; Salina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):75-7. PubMed ID: 18800419
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological regulation of emotional stress reactions].
    Seredenin SB
    Vestn Ross Akad Med Nauk; 2003; (12):35-7. PubMed ID: 14724970
    [No Abstract]   [Full Text] [Related]  

  • 10. Anxiety and predisposition to audiogenic epilepsy in rats of different genotypes.
    Surina NM; Kalinina TS; Volkova AV; Malikova LA; Poletaeva II; Rayevsky KS; Fedotova IB
    Bull Exp Biol Med; 2011 May; 151(1):47-50. PubMed ID: 22442800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary treatments for psychological trauma from the perspective of peacekeepers.
    Ray SL
    Can J Nurs Res; 2009 Jun; 41(2):115-28. PubMed ID: 19650517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of afobazole on rats with bilateral local photothrombosis of vessels in the prefrontal cortex.
    Seredenin SB; Romanova GA; Shakova FM
    Bull Exp Biol Med; 2008 Feb; 145(2):207-9. PubMed ID: 19023970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic anxiolytic treatment: benefit and risk.
    Marks J
    Adv Biochem Psychopharmacol; 1985; 40():173-83. PubMed ID: 2862763
    [No Abstract]   [Full Text] [Related]  

  • 14. The science of anxiety. Why do we worry ourselves sick? Because the brain is hardwired for fear, and sometimes it short-circuits.
    Gorman C
    Time; 2002 Jun; 159(23):46-54. PubMed ID: 12066497
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of condition of health and adaptation capabilities of military servicemen].
    Glad'ko VV; Maksiukova SA; Kakhishvili NN; Gaĭvoronskiĭ DA
    Voen Med Zh; 2010 Mar; 331(3):20-4. PubMed ID: 20536057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety levels and related pharmacological drug treatment: a memorandum for the third millennium.
    Pasquini M; Berardelli I
    Ann Ist Super Sanita; 2009; 45(2):193-204. PubMed ID: 19636172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical and psychological prediction of professional readiness of graduates of military school].
    Vorona AA; Gerasimenko VD; Kozlovskiĭ ÉA; Kukushkin IuA; Bogomolov AV
    Voen Med Zh; 2012 Jan; 333(1):40-4. PubMed ID: 22545450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychophysiological and social-and-psychological aspects of adaptation to military service in the European North of Russia in the servicemen called from different regions].
    Mosiagin IG; Malinitskiĭ AK
    Voen Med Zh; 2007 Mar; 328(3):39-42, 96. PubMed ID: 17580478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Administration of afobasol for correction of mental disorders in celiac disease patients].
    Oreshko LS
    Ter Arkh; 2008; 80(10):13-6. PubMed ID: 19105406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychological changes during propericiazine (Neuleptil) treatment of adolescents with scholastic adaptation difficulties].
    Ronco P; Davy M
    Minerva Med; 1968 May; 59(40):2357-64. PubMed ID: 5653334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.